Metabolic Research
Retatrutide
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
BPC-157 is a synthetic 15-residue peptide studied mainly in laboratory models of tissue injury, with clinical efficacy remaining unestablished.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Experimental pentadecapeptide
BPC-157 is a pentadecapeptide reported as a fragment related to a gastric protein preparation called body protection compound. The experimental sequence is GEPPPGKPADDAGLV. Its name identifies a particular peptide studied in repair models; it does not establish a general tissue-healing function in humans.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Experiments suggest several cellular responses rather than one conclusively established receptor mechanism. Rat tendon fibroblasts showed altered migration, actin organization, and phosphorylation of focal adhesion kinase and paxillin. Separate work examined growth hormone receptor expression. These observations describe experimental signaling responses, not proof of a unified therapeutic mechanism.
A 2011 study examined rat tendon explants and cultured fibroblasts. BPC-157 increased outgrowth and migration and improved survival during oxidative challenge, but did not directly increase proliferation in the tested culture conditions. [1]
Rat fibroblast experiments reported increased growth hormone receptor expression and greater responses when growth hormone was also present. This is a cellular interaction finding; it does not show that BPC-157 raises circulating growth hormone. [2]
A surgically transected rat Achilles tendon model reported differences in functional recovery, tissue organization, and mechanical measurements. Such injury models address specific repair questions and cannot establish outcomes for human tendon disorders. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The cited evidence consists of rodent experiments and isolated cells. It provides hypotheses about migration, stress responses, and repair biology, but no controlled clinical demonstration of faster recovery or restored function in people. Human efficacy should not be inferred from consistent-looking animal endpoints alone.
Species differences, artificial injuries, and laboratory exposure conditions limit translation. Studies measuring signaling or histology do not establish durable clinical benefit or long-term safety. The cited preparations also do not verify the identity, composition, or performance of any WYZ Labs material.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Rat tendon explants and fibroblasts; migration and stress-response endpoints.
Rat cells; receptor expression and responses to added growth hormone.
Rat surgical-injury model with mechanical, functional, and tissue endpoints.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COA